D-0416-2015 Class II Terminated

Recalled by Heritage Pharmaceuticals, Inc. — Eatontown, NJ

FDA drug recall D-0416-2015 was initiated by Heritage Pharmaceuticals, Inc. on Feb 25, 2015 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes. The recall status is terminated (terminated Feb 26, 2016). Affected quantity: 24,344 vials.

Recall details

Product Type
Drugs
Report Date
Mar 25, 2015
Initiation Date
Feb 25, 2015
Termination Date
Feb 26, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24,344 vials

Product description

RIFAMPIN for Injection,USP, 600 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724 NDC 23155-340-31

Reason for recall

Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.

Distribution pattern

Nationwide

Code information

Lot # VRIA002; Exp. 08/16, VRIA003; Exp. 09/16, VRIA004; Exp. 09/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0416-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0416-2015. Report a data issue: hello@regdatalab.com.